$ Value
$98K
Shares
12,675
Price
$8
Filed
Dec 19
Insider
Name
Nuss John
Title
CHIEF SCIENTIFIC OFFICER
CIK
0001874108
Roles
Transaction Details
Transaction Date
2025-12-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
489,481
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock. | Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. | Represents the weighted average share price of an aggregate total of 12,675 shares sold in the price range of $7.595 to $7.85. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.
Filing Info
Nuss John's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2025-12-18 | VTYX | ▼ | $98K |
Other Insiders at VTYX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Subramaniam Somu | — | — | 2026-03-04 |
| HULME ALLISON | — | — | 2026-03-04 |
| GUJRATHI SHEILA | — | — | 2026-03-04 |
| White William Richard | — | — | 2026-03-04 |
| Cadoret-Manier Onaiza | — | — | 2026-03-04 |
|
Moore Matthew Richard
Chief Operating Officer
|
— | — | 2026-03-04 |
|
Nuss John
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-03-04 |
|
Mohan Raju
CEO AND PRESIDENT
|
— | — | 2026-03-04 |
|
Forman Mark S
Chief Medical Officer
|
— | — | 2026-03-04 |
|
Gonzales Roy
Senior VP, Finance
|
— | — | 2026-03-04 |